Detection of the Th17 signature cytokine IL17 in purified CD4+T-cells was limited to few individuals and therefore we could not substantiate whether the increase in IL23R+CD4+T-cells in SPMS and PPMS reflects a true increase in Th17 activity or a potential for increased Th17 effector function in progressive MS. Here, CD4 is linked to myeloid sarcoma.